-
Subject Areas on Research
-
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection.
-
A 2020 Banff Antibody-mediatedInjury Working Group examination of international practices for diagnosing antibody-mediated rejection in kidney transplantation - a cohort study.
-
A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.
-
Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection.
-
Addition of interleukin-6 receptor blockade to carfilzomib-based desensitization in a highly sensitized nonhuman primate model.
-
Allo-Specific Humoral Responses: New Methods for Screening Donor-Specific Antibody and Characterization of HLA-Specific Memory B Cells.
-
Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.
-
Allosensitization in cardiac transplantation: shooting at a moving target.
-
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease.
-
Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen.
-
Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies.
-
Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work?
-
Antibody desensitization therapy in highly sensitized lung transplant candidates.
-
Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology.
-
Antibody-coated erythrocytes induce secretion of tumor necrosis factor by human monocytes: a mechanism for the production of fever by incompatible transfusions.
-
Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation.
-
Antibody-mediated rejection--an ounce of prevention is worth a pound of cure.
-
B cells in transplant tolerance and rejection: friends or foes?
-
BAFF promotes heightened BCR responsiveness and manifestations of chronic GVHD after allogeneic stem cell transplantation.
-
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
-
Banff Lung Report: Current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR).
-
Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies.
-
Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function.
-
Biochemical characterization of antibodies submitted as reactive with glycophorin species.
-
CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients.
-
CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy.
-
CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8.
-
Captopril-enhanced binding of PlA1 (HPA-1a) antibodies in posttransfusion purpura.
-
Casting a smaller net into a bigger donor pool: A single center's experience with the new kidney allocation system.
-
Cellular immunology markers postransplantation predictive of long-term graft outcome.
-
Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes.
-
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans.
-
Class II alloantibody and mortality in simultaneous liver-kidney transplantation.
-
Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood.
-
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.
-
Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
-
Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia.
-
Cross-reactivity of primate alloantigens: absorption of anti-HL-A reactivity from human alloantisera by chimpanzee lymphocytes.
-
Current challenges and opportunities in the management of antibody-mediated rejection in lung transplantation.
-
Daratumumab in Sensitized Kidney Transplantation: Potentials and Limitations of Experimental and Clinical Use.
-
Desensitization and management of allograft rejection.
-
Detection of platelet isoantibodies by (3H)serotonin platelet release and its clinical application to the problem of platelet matching.
-
Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.
-
Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
-
Development of donor-specific and non-donor-specific HLA-DP antibodies post-transplant: the role of epitope sharing and epitope matching.
-
Differential effects of donor-specific alloantibody.
-
Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?
-
Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants.
-
Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin.
-
Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort.
-
Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization.
-
Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.
-
Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation.
-
Experimental transfusion reactions in monkeys: haemolytic, coagulant and renal effects of transfused isoimmune IgG and IgM.
-
Gene therapy with an E2F transcription factor decoy inhibits cell cycle progression in rat anti-Thy 1 glomerulonephritis.
-
HLA antibodies and soluble CD30 are associated with poor renal graft outcome: updated results of a single-center cross-sectional study.
-
Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions.
-
Hemolytic transfusion reactions caused by failure of commercial antiglobulin reagents to detect complement.
-
Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection.
-
High-dose intravenous immunoglobulin for severe platelet alloimmunization.
-
Histocompatibility testing and mixed lymphocyte culture responses in chimpanzee families.
-
Histopathologic changes in anti-angiotensin II type 1 receptor antibody-positive kidney transplant recipients with acute rejection and no donor specific HLA antibodies.
-
Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study.
-
Human B cell alloantigens: expression of MB and MT determinants.
-
Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets.
-
IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.
-
IVIG therapy in neonatal isoimmune thrombocytopenic purpura and alloimmunization thrombocytopenia.
-
Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.
-
IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients.
-
Immune hemolytic transfusion reactions in monkeys: activation of the kallikrein system.
-
Improved renal function in mouse kidney allografts lacking MHC class I antigens.
-
In vivo tumor localization using tumor-specific monkey xenoantibody, alloantibody, and murine monoclonal xenoantibody.
-
Induction of tolerance to solubilized rat histocompatibility antigens.
-
Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era.
-
Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity.
-
Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations.
-
Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation.
-
Isoantibody specificity in post-transfusion purpura.
-
Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.
-
Lung Transplantation and the Era of the Sensitized Patient.
-
Lutheran antigens, CD44-related antigens, and Lutheran regulatory genes.
-
Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
-
Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model.
-
Mediation of hyperacute rejection of rat hepatic allografts by RT-1 antigens.
-
Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation.
-
Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation.
-
Neonatal alloimmune thrombocytopenic purpura.
-
Neonatal alloimmune thrombocytopenic purpura: a case report.
-
Non-HLA antibodies in transplantation: when do they matter?
-
Nontoxic nerve guide tubes support neovascular growth in transected rat optic nerve.
-
Overcoming Chronic Rejection-Can it B?
-
PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets.
-
Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment.
-
Perception of low-titer group A plasma and potential barriers to using this product: A blood center's experience serving community and academic hospitals.
-
Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation.
-
Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications.
-
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study.
-
Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival.
-
Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.
-
Prevention of graft-versus-host disease by a novel immunosuppressant, PG490-88, through inhibition of alloreactive T cell expansion.
-
Prevention trumps treatment of antibody-mediated transplant rejection.
-
Prolonged survival of class II transactivator-deficient cardiac allografts.
-
Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
-
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group.
-
Red blood cell alloimmunization mitigation strategies.
-
Reduced antigenicity of formaldehyde-fixed arterial allografts and their potential clinical application.
-
Region-specific anti-thyroid hormone receptor (TR) antibodies detect changes in TR structure due to ligand-binding and dimerization.
-
Residual risk of D alloimmunization: is it time to feel safe about platelets from D+ donors?
-
Role of C1q complement fixing antibody assay in therapeutic plasma exchange management of pediatric cardiac antibody mediated rejection.
-
Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods.
-
Seek and you will find: antibody and the liver.
-
Sensitization and Desensitization in Vascularized Composite Allotransplantation.
-
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report.
-
Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report.
-
Serological and biochemical characterization of monoclonal antibodies against red cell markers related to expression of Lutheran blood group antigens.
-
Serum immunoglobulins. 3. Abnormalities associated with chronic urticaria in children.
-
Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
-
Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection.
-
Spotlight on pathogenesis of TRALI: HNA-3a (CTL2) antibodies.
-
Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation.
-
Successful treatment of immune thrombocytopenic purpura with anti-D antibody following a cadaveric liver transplant for hepatoblastoma.
-
The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients.
-
The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
-
The clinical relevance of alloantibody in liver transplantation.
-
The effect of soluble complement receptor type 1 on hyperacute allograft rejection.
-
The problem of transplanting the sensitized patient: whose problem is it?
-
The role of B cells in solid organ transplantation.
-
The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat.
-
The role of donor-specific HLA alloantibodies in liver transplantation.
-
Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine.
-
Thromboxane augmentation of alloreactive T cell function.
-
Transplanting the highly sensitized patient: trials and tribulations.
-
Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
-
Two classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII.
-
Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients.
-
Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens.
-
Vincristine therapy for severe platelet alloimmunization.
-
[Association between HSV-2 infection and serum anti-rat brain antibodies in patients with autism].